Literature DB >> 15905540

B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.

Louise Birrell1, Liudmila Kulik, B Paul Morgan, V Michael Holers, Kevin J Marchbank.   

Abstract

Complement receptor type 2 (CR2/CD21), in association with CD19, plays an important role in enhancing mature B cell responses to opsonized Ags. We have shown that mice expressing a human CR2/CD21 (hCR2/CD21) transgene during the CD43(+)/CD25(-) late pro-B cell stage of B cell development demonstrate marked changes in subsequent B cell ontogeny. In the present study, we show that the humoral immune response to the T cell-dependent Ag, sheep RBC, is muted severely in a manner inversely proportional to B cell expression level of hCR2. Individual Ag-specific IgG isotypes vary in the degree to which they are affected but all are reduced while IgM titers are normal. A substantial reduction in germinal centers, both in size and frequency, in the spleens of immunized hCR2 transgenic mice demonstrates a failure to maintain germinal center reaction. However, both IgM expression levels and LPS-proliferative responses appear fully intact in B cells from hCR2-positive mice, suggesting that this alteration in B cell phenotype is different qualitatively from that of specific Ag-defined anergy models. These data suggest that the unresponsiveness to T-dependent Ags displayed by hCR2-positive B cells is linked to an increase in the level of stimulus required to propel the B cell into a fully activated state and thus a normal humoral immune response to Ags. We conclude that this phenotype and these mice may offer an additional means to dissect mechanisms underlying B cell tolerance and Ag responsiveness both in bone marrow and periphery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905540     DOI: 10.4049/jimmunol.174.11.6974

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.

Authors:  Kazushi Tanimoto; Yoshihiro Yakushijin; Hiroshi Fujiwara; Masaki Otsuka; Koichi Ohshima; Atsuro Sugita; Akira Sakai; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2009-04-11       Impact factor: 2.490

2.  Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells.

Authors:  Rhonda L Taylor; Mark N Cruickshank; Mahdad Karimi; Han Leng Ng; Elizabeth Quail; Kenneth M Kaufman; John B Harley; Lawrence J Abraham; Betty P Tsao; Susan A Boackle; Daniela Ulgiati
Journal:  Cell Mol Immunol       Date:  2015-02-02       Impact factor: 11.530

3.  Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3.

Authors:  Jason Twohig; Liudmila Kulik; Catherine Haluszczak; Jason Reuter; Andreas Rossbach; Melanie Bull; V Michael Holers; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2007-03-26       Impact factor: 4.407

4.  Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.

Authors:  Isabel Y Pappworth; Christine Hayes; Jason Dimmick; B Paul Morgan; V Michael Holers; Kevin J Marchbank
Journal:  Immunobiology       Date:  2011-06-25       Impact factor: 3.144

5.  Insights Into the Structure-Function Relationships of Dimeric C3d Fragments.

Authors:  Ayla A Wahid; Rhys W Dunphy; Alex Macpherson; Beth G Gibson; Liudmila Kulik; Kevin Whale; Catherine Back; Thomas M Hallam; Bayan Alkhawaja; Rebecca L Martin; Ingrid Meschede; Maisem Laabei; Alastair D G Lawson; V Michael Holers; Andrew G Watts; Susan J Crennell; Claire L Harris; Kevin J Marchbank; Jean M H van den Elsen
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

6.  Whole-Transcriptome Profiling and circRNA-miRNA-mRNA Regulatory Networks in B-Cell Development.

Authors:  Jie Pan; Saineng Hu; Xuanyao Ren; Hao Hu; Xiaoying Deng; Bo Yu; Inma Cobos; Xiaofan Chen; Wei Zhang
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

7.  Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice.

Authors:  Jason P Twohig; Isabel Y Pappworth; Baalasubramanian Sivasankar; Liudmila Kulik; Melanie Bull; V Michael Holers; Eddie C Y Wang; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2009-04-08       Impact factor: 4.407

8.  Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).

Authors:  Isabel Y Pappworth; Liudmila Kulik; Catherine Haluszczak; Jason W Reuter; V Michael Holers; Kevin J Marchbank
Journal:  Mol Immunol       Date:  2009-02-01       Impact factor: 4.407

9.  A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice.

Authors:  Yong-Gang He; Isabel Y Pappworth; Andreas Rossbach; Joshua Paulin; Tarirai Mavimba; Christine Hayes; Liudmila Kulik; V Michael Holers; Andrew M Knight; Kevin J Marchbank
Journal:  Immunobiology       Date:  2017-10-04       Impact factor: 3.144

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.